When an itch strikes, scratching usually brings relief after a few moments. Scientists have now uncovered part of the biological system that tells the brain when enough scratching has occurred. The discovery reveals how the nervous system naturally limits scratching and may help explain why this process breaks down in people with chronic itch disorders. The findings were presented at the 70th Biophysical Society Annual Meeting.
Researchers from the laboratory of Roberta Gualdani at the University of Louvain in Brussels identified an unexpected role for a molecule known as TRPV4 in itch triggered by mechanical stimulation, such as scratching.
“We were initially studying TRPV4 in the context of pain,” Gualdani explained. “But instead of a pain phenotype, what emerged very clearly was a disruption of itch, specifically, how scratching behavior is regulated.”
TRPV4 and the Nervous System
TRPV4 is part of a family of ion channels that function like tiny molecular gateways in sensory nerve cells. These channels allow ions to move through cell membranes in response to physical or chemical changes. They help the nervous system detect sensations including temperature, pressure, and tissue stress.
Scientists have suspected for years that TRPV4 plays a role in sensing mechanical stimulation, but its involvement in itch, particularly chronic itch, has remained unclear and heavily debated.
To investigate more precisely, Gualdani’s team created genetically engineered mice in which TRPV4 was removed only from sensory neurons. Earlier studies had deleted the molecule throughout the entire body, making it difficult to determine exactly where it was acting.
Using genetic analysis, calcium imaging, and behavioral testing, the researchers found that TRPV4 appears in touch sensitive neurons known as Aβ low-threshold mechanoreceptors (Aβ-LTMRs). The channel was also present in certain sensory neurons connected to itch and pain pathways, including neurons expressing TRPV1.
Why Scratching Sometimes Does Not Stop
The team then created a chronic itch condition in mice that resembled atopic dermatitis. The results surprised the researchers. Mice missing TRPV4 in sensory neurons scratched less often overall, but each scratching episode lasted much longer than normal.
“At first glance, that seems paradoxical,” Gualdani said. “But it actually reveals something very important about how itch is regulated.”
According to the study, TRPV4 does not simply create the sensation of itch. Instead, it appears to help activate a negative feedback signal in mechanosensory neurons. This signal informs the spinal cord and brain that scratching has provided enough relief.
Without that feedback system, the sense of satisfaction from scratching becomes weaker, causing scratching to continue for extended periods. Researchers say TRPV4 may therefore function as part of the nervous system’s internal “stop scratching” mechanism.
“When we scratch an itch, at some point we stop because there’s a negative feedback signal that tells us we’re satisfied,” Gualdani explained. “Without TRPV4, the mice don’t feel this feedback, so they continue scratching much longer than normal.”
Implications for Chronic Itch Treatments
The findings also suggest that TRPV4 has a more complicated role in itch than previously believed. In skin cells, the channel may help trigger itch sensations. In neurons, however, it appears to help control and limit scratching behavior.
That distinction could be important for future drug development.
“This means that broadly blocking TRPV4 may not be the solution,” Gualdani noted. “Future therapies may need to be much more targeted — perhaps acting only in the skin, without interfering with the neuronal mechanisms that tell us when to stop scratching.”
Chronic itch affects millions of people living with conditions such as eczema, psoriasis, and kidney disease, but treatment options remain limited. Researchers believe that understanding how the body controls itch, including the signals that tell us when to stop scratching, could eventually lead to more effective therapies.